Study of HS-20137 for moderate to severe plaque psoriasis
This trial tests an investigational drug called HS-20137 for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had plaque psoriasis for at least 6 months.
- Your psoriasis covers at least 3% of your body surface area (about the size of three palms).
- You have not had a severe allergic reaction to a biologic medicine or any of the drug's ingredients.
- You have not used certain psoriasis treatments within the past few weeks, or other biologics without the required waiting period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This study tests an experimental once-daily tablet for adults with moderate-to-severe plaque psoriasis who haven't had enough relief from standard creams or light therapy. The goal is to see if it can clear skin more effectively than placebo.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.